Identification Generic Name (2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide DrugBank Accession Number DB04108 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide (DB04108) ×  Close Weight Average: 346.487  Monoisotopic: 346.171498776  Chemical Formula C 19 H 26 N 2 O 2 S Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Methionine aminopeptidase 2 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as beta amino acids and derivatives. These are amino acids having a (-NH2) group attached to the beta carbon atom. Kingdom Organic compounds Super Class Organic acids and derivatives Class Carboxylic acids and derivatives Sub Class Amino acids, peptides, and analogues Direct Parent Beta amino acids and derivatives Alternative Parents Naphthalenes  /  N-acyl amines  /  Monosaccharides  /  Secondary carboxylic acid amides  /  Secondary alcohols  /  Sulfenyl compounds  /  Dialkylthioethers  /  Organopnictogen compounds  /  Organic oxides  /  Monoalkylamines  /  Hydrocarbon derivatives  /  Carbonyl compounds 
 
 
  show 2 more Substituents Alcohol  /  Amine  /  Aromatic homopolycyclic compound  /  Benzenoid  /  Beta amino acid or derivatives  /  Carbonyl group  /  Carboxamide group  /  Dialkylthioether  /  Fatty acyl  /  Fatty amide  /  Hydrocarbon derivative  /  Monosaccharide  /  N-acyl-amine  /  Naphthalene  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Organosulfur compound  /  Primary aliphatic amine  /  Primary amine  /  Secondary alcohol  /  Secondary carboxylic acid amide  /  Sulfenyl compound  /  Thioether 
 
 
  show 17 more Molecular Framework Aromatic homopolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key AIIOXZPEXXZCML-KKXDTOCCSA-N InChI InChI=1S/C19H26N2O2S/c1-3-24-12-11-17(20)18(22)19(23)21-13(2)15-10-6-8-14-7-4-5-9-16(14)15/h4-10,13,17-18,22H,3,11-12,20H2,1-2H3,(H,21,23)/t13-,17-,18-/m0/s1 IUPAC Name (2S,3S)-3-amino-5-(ethylsulfanyl)-2-hydroxy-N-[(1S)-1-(naphthalen-1-yl)ethyl]pentanamide SMILES [H][C@](N)(CCSCC)[C@]([H])(O)C(=O)N[C@@]([H])(C)C1=C2C=CC=CC2=CC=C1 References General References Not Available External Links PubChem Compound 5287684 PubChem Substance 46508224 ChemSpider 4450002 ZINC ZINC000012504146 PDBe Ligand AO1 PDB Entries 1r5g Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.00918 mg/mL ALOGPS logP 2.55 ALOGPS logP 2.24 Chemaxon logS -4.6 ALOGPS pKa (Strongest Acidic) 12.57 Chemaxon pKa (Strongest Basic) 8.75 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 75.35 Å 2 Chemaxon Rotatable Bond Count 8 Chemaxon Refractivity 100.55 m 3 ·mol -1 Chemaxon Polarizability 38.96 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9961 Blood Brain Barrier + 0.6308 Caco-2 permeable - 0.622 P-glycoprotein substrate Substrate 0.788 P-glycoprotein inhibitor I Non-inhibitor 0.8056 P-glycoprotein inhibitor II Non-inhibitor 0.841 Renal organic cation transporter Non-inhibitor 0.8616 CYP450 2C9 substrate Non-substrate 0.7859 CYP450 2D6 substrate Non-substrate 0.6918 CYP450 3A4 substrate Non-substrate 0.5 CYP450 1A2 substrate Inhibitor 0.5101 CYP450 2C9 inhibitor Non-inhibitor 0.8022 CYP450 2D6 inhibitor Non-inhibitor 0.6743 CYP450 2C19 inhibitor Non-inhibitor 0.6996 CYP450 3A4 inhibitor Non-inhibitor 0.6842 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.5773 Ames test Non AMES toxic 0.6518 Carcinogenicity Non-carcinogens 0.8803 Biodegradation Not ready biodegradable 0.9876 Rat acute toxicity 2.3330 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9917 hERG inhibition (predictor II) Inhibitor 0.7547    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more Binding Properties × Property Measurement pH Temperature (°C) References IC 50 (nM) 22 7.4 22 A30235 IC 50 (nM) 30 N/A N/A A30103 
 
 
  Details 
 
 
   Binding Properties 1.  Methionine aminopeptidase 2 Kind Protein Organism Humans Pharmacological action Unknown General Function Poly(a) rna binding Specific Function Cotranslationally removes the N-terminal methionine from nascent proteins. The N-terminal methionine is often cleaved when the second residue in the primary sequence is small and uncharged (Met-Ala... Gene Name METAP2 Uniprot ID P50579 Uniprot Name Methionine aminopeptidase 2 Molecular Weight 52891.145 Da References Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [ Article ]  Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [ Article ]  Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 